NR4A1 and breast cancer: We have found modest evidence for an association between intra-cellular expression of TGM2 in the tumour cytoplasm and an improved prognosis in early breast cancer with a bigger effect in hormone-receptor-negative disease than in hormone-receptor positive disease.